[1] |
Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis[J].Nat Rev Endocrinol,2011,7(4):219–231.
|
[2] |
Janssen OE, Mehlmauer N, Hahn S,et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome [J]. Eur J Endocrinol, 2004,150(3):363–369.
|
[3] |
Anaforoglu I, Topbas M, Algun E. Relative associations of polycystic ovarian syndrome versus metabolic syndrome with thyroid function, volume, nodularity and autoimmunity[J]. J Endocrinol Invest,2011,34(9):259–264.
|
[4] |
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS). Hum Reprod,2004,19(1):41–47.
|
[5] |
Wu X, Zhang Z, Su Y. Functional states of pituitary-ovary, adrenal and thyroid axes in women with polycystic ovarian syndrome[J]. Zhonghua Fu Chan Ke Za Zhi,1998,33(3):153–156.
|
[6] |
Kachuei M, Jafari F, Kachuei A,et al.Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome [J]. Arch Gynecol Obstet,2012,285(3):853–856.
|
[7] |
Bjoro T, Holmen J, Krüger O,et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT) [J]. Eur J Endocrinol,2000,143(5):639–647.
|
[8] |
Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications[J]. J Clin Endocrinol Metab,2006,91(7):2587–2591.
|
[9] |
Sahu MT, Das V, Mittal S, et al.Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome[J].Arch Gynecol Obstet,2010,28l(2):215–220.
|
[10] |
van den Boogaard E, Vissenberg R, Land JA, et al.Significance of(sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy:a systematic review[J].Ham Reprod Update, 2011,17(5):605–619.
|
[11] |
Paknys G, Kondrotas AJ, Kevelaitis E. Risk factors and pathogenesis of Hashimoto's thyroiditis[J]. Medicina (Kaunas),2009,45(7):574–583.
|
[12] |
Rose NR. The genetics of autoimmune thyroiditis: the first decade[J].J Autoimmun, 2011,37(2):88–94.
|
[13] |
Ramos Cirilo PD, Rosa FE, Moreira Ferraz MF, et al.Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome[J]. Gynecol Endocrinol, 2012,28(3):190–194.
|
[14] |
Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors[J]. J Endocrinol,2011,210(1):5–14.
|
[15] |
岳峰,张铁,李秀莲.多囊卵巢综合征患者血清瘦素水平与性激素间的相关性研究[J/CD].中华临床医师杂志:电子版,2015,9(4):590–592.
|
[16] |
詹晶,许良智.甲状腺功能异常与多囊卵巢综合征[J/CD].中华妇幼临床医学杂志:电子版,2011,7(4):375–378.
|